Day Zero Diagnostics Wins $6.2M From Accelerator
May 12 2020

CARB-X award to fund DZD’s new technology to rapidly identify pathogens and determine their drug resistance profile

Read More
DZD Using CARB-X Award to Commercialize Antibiotic-Resistance Testing Platform
May 11 2020

360Dx reporter John Gilmore covers DZD’s plans to advance new diagnostic system with CARB-X funding

Read More
CARB-X Awards DZD $6.2M to Develop New Test To Diagnose Deadly Superbug Infections
May 11 2020

Funding award is the first whole genome sequencing and machine learning technology in CARB-X portfolio

Read More
New Genomic Tests Aim to Diagnose Deadly Infections Faster
February 24 2020

DZD included in the new class of diagnostics for infectious diseases

Read More
Diagnostic Startups Take on Growing Threat of Antibiotic-Resistant Bugs
January 14 2020

DZD featured in WSJ review of emerging diagnostic companies

Read More
Genomics Links Fecal Transplant Recipient Infections to Drug-Resistant E. coli Donor
October 31 2019

EpiXact uses sequencing to confirm cause of patient death in a clinical trial with wide ranging implications

Read More
Top